Clik here to view.
Immunotherapy Combination Proving Effective for Peritoneal Mesothelioma
Update: 07/14/2021: The annual follow-up of this study provided new data on atezolizumab and bevacizumab for peritoneal mesothelioma. Most clinical trials experimenting with novel treatments focus on...
View ArticleClik here to view.
Johnson & Johnson Considering Subsidiary Bankruptcy in Face of Talc Asbestos...
The next chapter in the Johnson & Johnson asbestos saga is almost written. It might be defined by one word: bankruptcy. According to reports from the Wall Street Journal and CNBC, the...
View ArticleClik here to view.
New Mesothelioma Trial Pairs Immune Checkpoint Inhibitor With Anti-Mesothelin...
There are various types of immunotherapy. Could pairing two of them work for malignant mesothelioma? A new study out of the National Cancer Institute is combining an immune checkpoint inhibitor with a...
View ArticleClik here to view.
Memorial Sloan Kettering Opens Immunotherapy Trial for Mesothelioma
Researchers at Memorial Sloan Kettering Cancer Center hope they can discover the safest dose for mesothelin‑targeted CAR T‑cell therapy. This is the next step in ongoing research into whether this type...
View ArticleClik here to view.
What Are the Most Common Signs of Pleural Mesothelioma?
One of the toughest parts of fighting mesothelioma is detecting the rare cancer. Most people don’t know they have it until the tumors have progressed into organ cavities. Early detection is important...
View ArticleClik here to view.
Potential New Treatment Option for Peritoneal Mesothelioma
Treatment for peritoneal mesothelioma is today where treatment was three years ago for pleural mesothelioma. Tumor treating fields are not yet acceptable for non-surgical cases. Immunotherapy is also...
View ArticleClik here to view.
FDA Approves Therapy as Orphan Drug for Mesothelioma
The U.S. Food and Drug Administration (FDA) granted ONCOFID‑P “orphan drug status” for treating malignant mesothelioma. ONCOFID‑P is a combination of paclitaxel and hyaluronic acid. Paclitaxel is a...
View ArticleClik here to view.
Johnson & Johnson Sued by Black Women’s Group for Talc Baby Powder
Johnson & Johnson, the manufacturer at the center of asbestos lawsuits due to contaminated talc products, is being sued by a black women’s group, according to the New York Times. The National...
View ArticleImmunotherapy or Chemotherapy? Doctors Weigh in on Preference for Mesothelioma
The first preference for treating mesothelioma is surgery. If you can remove the cancerous tumors in bulk, quickly, then the chances of a long and healthy life increase dramatically. The issue is...
View ArticleClik here to view.
Importance of Second COVID-19 Vaccine Dose for Mesothelioma Patients
Since the start of the COVID‑19 coronavirus pandemic, use of the term “immunocompromised” has surged — and for good reason. Immunocompromised people are at the highest risk of a severe, possibly...
View ArticleClik here to view.
Oral Chemotherapy Drug Olaparib Being Tested for Mesothelioma
A popular oral chemotherapy for treating genetic mutations is the focus of a new clinical trial for mesothelioma. The drug, olaparib, is a maintenance therapy for advanced ovarian cancer cases with...
View ArticleClik here to view.
Cancer Centers Linked to Colleges Provide Best Survival for Peritoneal...
The top mesothelioma cancer centers in the world offer experienced staff, plenty of treatment options and additional support resources. There’s a subset within the segment of top cancer hospitals:...
View ArticleClik here to view.
Should People Trust What They Read About Mesothelioma?
Is the internet trustworthy? That’s a loaded question, one without a clear‑cut answer. Zoom in a little closer: Is the internet trustworthy for researching cancer? It’s a case‑by‑case basis. Some...
View ArticleClik here to view.
Appeals Court Defends $29 Million Mesothelioma Verdict Against Johnson & Johnson
With bankruptcy in mind, Johnson & Johnson took another big shot in its fight against mesothelioma claims. According to a report from Bloomberg Law, a California appellate court ruled in favor of a...
View ArticleClik here to view.
Adding a New Type of Checkpoint Inhibitor to Mesothelioma Treatment
Using checkpoint inhibitors is the latest hot‑button topic among oncologists and cancer specialists. Mesothelioma is no different. Most use immune checkpoint inhibitors, a form of immunotherapy....
View ArticleClik here to view.
Can Opdivo and Yervoy Work for Peritoneal Mesothelioma?
Opdivo and Yervoy are helping people with pleural mesothelioma live longer. Could the same happen for people with peritoneal mesothelioma? The U.S. Food and Drug Administration approved Opdivo and...
View ArticleClik here to view.
What Are the Most Common Signs of Peritoneal Mesothelioma?
Peritoneal mesothelioma, a cancer of the abdominal lining, often deceives doctors, patients and more of its presence. The main reason for this is the signs of peritoneal mesothelioma aren’t unique to...
View ArticleClik here to view.
Where Does HITHOC Fit as a Pleural Mesothelioma Treatment?
Hot chemotherapy seems to supplement radical surgery quite well, especially for peritoneal mesothelioma. For pleural mesothelioma, the feelings are divided. Numerous reports emerged recently about the...
View ArticleClik here to view.
Clinical Trial Tests Different Mesothelioma Chemotherapy Drugs in HIPEC
Do the chemotherapy drugs used during HIPEC matter for survival? That’s the basis of a new clinical trial at the National Cancer Institute. Researchers are looking into whether changing the drugs used...
View ArticleClik here to view.
$26.5 Million to Mesothelioma Victim in Talc Baby Powder Lawsuit
A California jury ruled in favor of a 35‑year‑old mesothelioma victim against Johnson & Johnson, the manufacturer at the center of thousands of lawsuits. Johnson & Johnson makes a talc Baby...
View Article
